Colliers Brokers Corbus Pharmaceuticals' 36,471-SF Office Lease Renewal at 500 River Ridge Drive in Norwood
Colliers, a leading diversified professional services and investment management company, has facilitated a lease renewal for Corbus Pharmaceuticals Holdings, Inc. at 500 River Ridge Drive in Norwood, Massachusetts, the firm announced. The renewal encompasses 36,471 square feet within the Class A office property located in River Ridge Office Park, reinforcing the clinical-stage biopharmaceutical company's continued commitment to the Greater Boston market and its focus on sustaining the operational infrastructure needed to advance its research pipeline.
Vice Chair Curtis Cole, Vice President Sean Hannigan, and Senior Vice President Tim Allen of Colliers represented the tenant in the transaction. JLL, led by Nat Kessler, represented the landlord, River Ridge Limited Partnership.
Deal Details: Class A Suburban Office Real Estate Along Route 128 Corridor
The renewed premises at 500 River Ridge Drive sit within River Ridge Office Park, a Class A suburban office property strategically positioned along Route 1 with direct access to Route 128 and Interstate 95. According to Colliers, that connectivity places Corbus within reach of Greater Boston's key business and life sciences corridors. The property's institutional-quality features and accessibility have continued to attract tenants seeking well-located, high-performance suburban office space, according to Colliers.
Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on advancing innovative treatments for cancer and obesity. Lease terms were not disclosed.
Greater Boston Life Sciences Context
Greater Boston's life sciences ecosystem has provided demand for office real estate across both urban and suburban submarkets. According to Colliers' Life Sciences Market Outlook 2026, research-heavy life sciences space in Greater Boston has increased by approximately 20% over the past five years, supported by more than $8 billion in venture capital funding flowing into the region.
Colliers and Corbus on the Transaction
"Representing Corbus Pharmaceuticals in this renewal was about making sure the terms and the location worked for their business, today and into the future," said Sean Hannigan, Vice President at Colliers. "500 River Ridge continues to serve as a strong base for their team as they advance their research and operations."
"Renewing at 500 River Ridge reflects our confidence in this location as a foundation for our continued work," said Evan Moran, CFO of Corbus Pharmaceuticals. "Greater Boston's life sciences ecosystem, combined with our established presence here, positions us well as we move forward with our pipeline and business objectives."
About Colliers
Colliers operates as a global diversified professional services and investment management company with three business lines: Commercial Real Estate, Engineering, and Investment Management. The firm reports $5.6 billion in annual revenues, approximately 24,000 professionals worldwide, and $108 billion in assets under management.
Sources
Related Articles

Dunn Isaacson Rhee Signs 11,167-SF Lease at Silverstein Properties' 7 World Trade Center
Greystar, Marcus Partners Open 304-Unit Belstead Apartments in North Attleboro, Massachusetts

Oxford Properties Acquires One Marina Park Drive From Clarion Partners for $435M in Boston Seaport
